STOCK TITAN

Terns Pharmaceuticals, Inc. (TERN) Free Cash Flow by Year

TERN

Terns Pharmaceuticals, Inc. recorded an outflow of $82.2M in free cash flow in fiscal year 2025. This represents a decrease of 17.3% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Terns Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$82.2M
YoY -17.3%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TERN Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Free Cash Flow-$82.2M-17.3%-$70.1M-3.9%-$67.4M-36.6%-$49.4M-17.1%-$42.2M-38.7%-$30.4M

TERN Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Free Cash Flow-$19.1M-30.8%-$19.8M-20.2%-$18.9M-16.6%-$24.4M-7.1%-$14.6M+24.7%-$16.5M+20.5%-$16.2M-24.6%-$22.8M-58.7%-$19.4M-72.2%-$20.7M-54.0%-$13.0M-16.3%-$14.4M-6.2%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Terns Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Terns Pharmaceuticals, Inc.'s free cash flow in fiscal year 2025?

Terns Pharmaceuticals, Inc. recorded an outflow of $82.2M in free cash flow in fiscal year 2025.

How fast is Terns Pharmaceuticals, Inc.'s free cash flow growing?

Terns Pharmaceuticals, Inc. (TERN) free cash flow fell by 17.3% year over year, from -$70.1M to -$82.2M in fiscal year 2025.

How has Terns Pharmaceuticals, Inc.'s free cash flow changed over the years?

Across the 6 fiscal years this page covers, Terns Pharmaceuticals, Inc. (TERN) free cash flow went from -$30.4M in fiscal year 2020 to -$82.2M in fiscal year 2025.

Terns Pharmaceuticals, Inc. (TERN) reported -$19.1M in free cash flow in Q4 2025. This represents a decrease of 30.8% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Terns Pharmaceuticals, Inc. (TERN) reported on that line in every period on record.